Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Lynch Brian Joseph. Officer active across 1 company, notably Madrigal Pharmaceuticals, INC.. Cumulatively, 7 disclosures have been logged. Activity tracked since 23 December 2022. The latest transaction was disclosed on 23 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Brian Joseph Lynch is a declarant linked to Madrigal Pharmaceuticals, INC., where he is SVP and General Counsel. He has 7 filings in total, and across the 7 sampled filings the most frequent transaction nature is Option exercise, with a period from 2022-12-28 to 2024-01-25 and buy and sell amounts shown as EUR 0.